Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) made headlines in December when they announced they would be joining forces. Mega-mergers like this aren't common in the cannabis industry, especially not ones that fuse a pair of its bigger players.
But investors aren't too excited about this deal -- Aphria's stock price has slid in the weeks since the announcement, from more than $8 a share to under $7. The Ontario-based pot stock is still up around 35% year to date, however, wildly outperforming the Horizons Marijuana Life Sciences ETF, which is down 3%.
Has this month's slide opened up an opportunity to buy Aphria shares at a discount, or will the merger with Tilray drag the stock even further down?
Source Fool.com